Two new studies indicate that immunotherapy may benefit people with
Immunotherapy drug delays recurrence in kidney cancer patients
Treatment with an immunotherapy drug following kidney cancer surgery, prolonged
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (TNBC), neoadjuvant carboplatin plus
Why some melanoma patients do not respond to immunotherapy
By harnessing the immune system against cancer, immunotherapies have revolutionized
Combo Shows ‘Impressive’ Survival Results in First-Line RCC
The combination of lenvatinib and pembrolizumab outperforms sunitinib as first-line
Novel hydrogel slowly releases RNA nanovaccines to shrink tumors
Messenger RNA (mRNA) vaccines to prevent COVID-19 have made headlines
Why immunotherapy only works for some with head and neck cancer
University of Cincinnati researchers have discovered new clues into why
CAR NKT cells offer a promising novel immunotherapy for solid tumors
Natural killer T (NKT) cells, a type of immune cells
Algorithm personalizes which cancer mutations are best targets for immunotherapy
As tumor cells multiply, they often spawn tens of thousands
5 things to know about immunotherapy and breast cancer
If you follow news about medical breakthroughs, you have undoubtedly